Femara 2.5 mg

Dragon Pharma Femara 2.5 mg – Highly Potent Aromatase Inhibitor

Dragon Pharma Femara 2.5 mg is a synthetic formulation of Letrozole, a highly potent non-steroidal aromatase inhibitor belonging to the triazole class of compounds. Letrozole functions by competitively binding to the heme group of the aromatase enzyme (CYP19A1), thereby inhibiting the conversion of androstenedione and testosterone to estrone and estradiol. This mechanism provides researchers with one of the most potent tools available for studying estrogen biosynthesis suppression, with documented >98% inhibition of total body aromatization in research models.

If your laboratory requires reliable Dragon Pharma Femara for endocrine or estrogen-related research, this 100-tablet sachet delivers 250 mg total compound. For researchers studying complete estrogen suppression, letrozole-resistant mechanisms, or comparative aromatase inhibitor pharmacology, finding legit Femara from a verified source ensures consistent, reproducible data.

Why Athletes & Bodybuilders Are Researching Letrozole

Maximal estrogen suppression is sometimes necessary in research protocols involving highly aromatizable androgens. Letrozole research explores its effects on serum estradiol reduction, hypothalamic-pituitary-gonadal axis feedback, and downstream effects on water retention and lipid profiles. For researchers examining complete estrogen blockade, comparative AI potency studies, or androgen-only research models where estrogenic activity must be minimized, Letrozole provides the most potent aromatase inhibition available in research literature.

What Makes Dragon Pharma Femara 2.5 mg Different?

• ✔ Most potent non-steroidal AI – >98% aromatase inhibition in research models
• ✔ Triazole structure distinct from other AI classes for comparative studies
• ✔ 2.5 mg tablet format for potent, low-volume research dosing
• ✔ 100-tablet sachet enables extended research protocols (12+ weeks)

Note for researchers: Letrozole is the most potent aromatase inhibitor in common research use. For best results in maximal estrogen suppression studies, always source legit Femara from Dragon Pharma.

Product Specifications

Dosage & Research Guidelines

Research Dosing Guidelines

Based on available research literature, typical Letrozole dosing in rodent models falls within this range:

• ✔ 0.1 – 1 mg per kg in research models (maximal estrogen suppression at higher range)
• ✔ One 2.5 mg tablet provides a potent oral research dose
• ✔ One 100-tablet sachet provides 250 mg total compound for extended protocols
• ✔ Research protocols typically run 4-12 weeks for estrogen suppression studies

Tablet Dosing Guide

For research involving precise oral administration of Femara 2.5 mg tablets:

• ✔ Whole tablet = 2.5 mg dose (maximal suppression)
• ✔ Half tablet = 1.25 mg dose (moderate-high suppression)
• ✔ Quarter tablet = 0.625 mg dose (lower dose protocols)
• ✔ Tablets can be crushed and suspended for gavage studies
• ✔ Daily administration recommended for sustained suppression

How Researchers Are Using Letrozole

Letrozole is the benchmark for maximal estrogen suppression in research literature. Its exceptional potency and oral bioavailability make it the preferred choice for complete estrogen blockade studies.

Popular research stacks and comparisons include:

• ✔ Femara + Testosterone Enanthate — for androgen-only research models. View Enantat 250 →
• ✔ Femara + Arimidex — for comparative AI potency studies. View Arimidex →
• ✔ Femara + Aromasin — for non-steroidal vs steroidal AI comparison. View Aromasin →

Research Protocol Example (8 Weeks)

• ✔ Weeks 1-8: Letrozole 0.5-2.5 mg once daily oral
• ✔ Lower doses (0.5-1 mg) for moderate suppression; higher (2.5 mg) for maximal suppression
• ✔ Washout period: 14-21 days observation post-protocol

Important Considerations

• 🔬 Letrozole is the most potent non-steroidal AI – use lowest effective dose for your protocol
• 💊 Complete oral bioavailability (99.9%) ensures consistent exposure without food effects
• ⚠️ Research suggests near-complete (>98%) estrogen suppression at therapeutic doses
• 📦 Store tablets in original sachet with desiccant to prevent degradation
• 📦 Always source Dragon Pharma Femara from verified suppliers for research integrity

Lab Verification – Third-Party Test Results

At Dragon Pharma, every batch of research compounds is scheduled for independent third-party HPLC testing to verify purity, concentration, and identity. Below is the status for Dragon Pharma Femara 2.5 mg.

What Will Be Tested?

• ✔ Compound Identity: HPLC-UV confirmation of Letrozole
• ✔ Purity (%): Peak area normalization vs reference standard
• ✔ Dosage Uniformity: Random sampling from each batch
• ✔ Heavy Metals & Residual Solvents: Safety profile verification

Why Third-Party Testing Matters

With the proliferation of unverified research chemicals, independent lab analysis is the only method to confirm compound identity and purity. Legit Femara should meet strict quality specifications. Dragon Pharma is building a reputation for full transparency — batch-specific COAs will be published here as they become available.

For more information on Letrozole research and aromatase inhibition, refer to this PubMed study on letrozole pharmacology.

Shipping & Product Authenticity

What to Expect

• ✔ Orders processed within 24–48 hours after payment confirmation
• ✔ USA Domestic shipping via USPS/UPS/FedEx — tracking included
• ✔ International tracking available (update frequency varies by destination)
• ✔ Sachets are shipped in protective packaging with desiccant

How to Verify You Have Legit Femara

Counterfeit research compounds are a genuine concern. Here's how to confirm you're receiving authentic Dragon Pharma Femara:

• ✔ QR code verification — each package includes a unique QR code. Scan to verify batch on Dragon Pharma's official database
• ✔ Scratch-off serial number — reveals a one-time use code for online verification
• ✔ Batch traceability — match batch number to our records
• ✔ Original sealed sachet — intact, tamper-evident foil packaging

For complete delivery details, tracking policy, international customs, and reshipment terms, please see our Shipping Info page.

Storage Guidelines

Storage Recommendations

• ✔ Store at 15–25°C (59–77°F) — controlled room temperature
• ✔ Keep in original sachet with desiccant until first use
• ✔ Protect from moisture, humidity, and direct light
• ✔ Keep away from heat sources
• ✔ Stable for up to 24 months when stored properly in sealed sachet

What to Avoid

• ❌ High humidity or moisture — can degrade tablet integrity
• ❌ Leaving sachet open after first use — reseal or store in airtight container
• ❌ Extreme temperatures (>30°C or <0°C)
• ❌ Storing in bathroom or near heat sources
• ❌ Using tablets that show discoloration, spots, or crumbling

Inspection Before Use

Before using Femara 2.5 mg tablets in your research, always inspect the product:

• ✔ Tablets should be intact, uniform in color and shape
• ✔ Sachet seal must be intact — do not use if seal is broken or shows tampering
• ✔ Check batch number and QR code for authenticity before use

Keep out of reach of children and unauthorized personnel. Follow institutional laboratory safety guidelines for handling research compounds.

Frequently Asked Questions